Open Access
Issue
J Oral Med Oral Surg
Volume 30, Number 1, 2024
Article Number 1
Number of page(s) 5
DOI https://doi.org/10.1051/mbcb/2024003
Published online 26 February 2024
  1. Glass IA, Swindlehurst CA, Aitken DA, McCrea W, Boyd E. Interstitial deletion of the long arm of chromosome 2 with normal levels of isocitrate dehydrogenase. J Med Genet 1989;26:127–130. [CrossRef] [PubMed] [Google Scholar]
  2. Association Française du SATB2. AFSATB2. [cited 2023 Oct 1]. Available from: https://www.associationfrancaisesatb2.org [Google Scholar]
  3. Zarate YA, Perry H, Ben-Omran T, Sellars EA, Stein Q, Almureikhi M, et al. Further supporting evidence for the SATB2-associated syndrome found through whole exome sequencing. Am J Med Genet A 2015;167A:1026–1032. [CrossRef] [Google Scholar]
  4. ClinVar. [cited 2023 Oct 1]. Available from: https://www.ncbi.nlm.nih.gov/clinvar/ [Google Scholar]
  5. Zarate YA, Smith-Hicks CL, Greene C, Abbott MA, Siu VM, Calhoun ARUL, et al. Natural history and genotype-phenotype correlations in 72 individuals with SATB2-associated syndrome. Am J Med Genet A 2018;176:925–935. [CrossRef] [PubMed] [Google Scholar]
  6. Zarate YA, Bosanko KA, Caffrey AR, Bernstein JA, Martin DM, Williams MS, et al. Mutation update for the SATB2 gene. Hum Mutat. 2019;40:1013–1029. [Google Scholar]
  7. Scott J, Adams C, Beetstra S, Zarate YA. SATB2-associated syndrome (SAS) and associated dental findings. Spec Care Dent Off Publ Am Assoc Hosp Dent Acad Dent Handicap Am Soc Geriatr Dent 2019;39:220–224. [Google Scholar]
  8. Scott J, Adams C, Simmons K, Feather A, Jones J, Hartzell L, et al. Dental radiographic findings in 18 individuals with SATB2-associated syndrome. Clin Oral Investig 2018;22:2947–2951. [CrossRef] [PubMed] [Google Scholar]
  9. Lai PY. Association of taurodontism with hypodontia: a controlled study. Pediatr Dent 1989;11:214–219. [PubMed] [Google Scholar]
  10. Döcker D, Schubach M, Menzel M, Munz M, Spaich C, Biskup S, et al. Further delineation of the SATB2 phenotype. Eur J Hum Genet 2014;22:1034–1039. [CrossRef] [PubMed] [Google Scholar]
  11. Zarate YA, Fish JL. SATB2-associated syndrome: mechanisms, phenotype, and practical recommendations. Am J Med Genet A 2017;173:327–337. [CrossRef] [PubMed] [Google Scholar]
  12. Li X, Ye X, Su J. The dental phenotype of primary dentition in SATB2-associated syndrome: a report of three cases and literature review. BMC Oral Health 2022;22:522. [CrossRef] [PubMed] [Google Scholar]
  13. Zarate YA, Bosanko KA, Thomas MA, Miller DT, Cusmano-Ozog K, Martinez-Monseny A, et al. Growth, development, and phenotypic spectrum of individuals with deletions of 2q33.1 involving SATB2. Clin Genet 2021;99:547–557. [CrossRef] [PubMed] [Google Scholar]
  14. Zarate YA, Örsell JL, Bosanko K, Srikanth S, Cascio L, Pauly R, et al. Individuals with SATB2-associated syndrome with and without autism have a recognizable metabolic profile and distinctive cellular energy metabolism alterations. Metab Brain Dis 2021; 36:1049–1056. [CrossRef] [PubMed] [Google Scholar]
  15. Britanova O, de Juan Romero C, Cheung A, Kwan KY, Schwark M, Gyorgy A, et al. Satb2 is a postmitotic determinant for upper-layer neuron specification in the neocortex. Neuron 2008;57: 378–392. [CrossRef] [PubMed] [Google Scholar]
  16. Li Z, Yuan J, Wei L, Zhou L, Mei K, Yue J, et al. SATB2 is a sensitive marker for lower gastrointestinal well-differentiated neuroendocrine tumors. Int J Clin Exp Pathol 2015;8:7072–7082. [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.